Common Cold (Rhinovirus)

Overview

Plain-Language Overview

The common cold is a very frequent illness caused by viruses, primarily affecting the nose and throat. It leads to symptoms like a runny nose, sneezing, sore throat, and sometimes a mild cough. This condition mainly impacts the upper respiratory system, which includes the nose, sinuses, and throat. Although it can cause discomfort and disrupt daily activities, it usually resolves on its own without serious complications. The immune system responds to the viral infection, which causes the typical symptoms. It is highly contagious and spreads easily through droplets when an infected person coughs or sneezes.

Clinical Definition

The common cold (rhinovirus) is an acute, self-limited viral infection of the upper respiratory tract caused predominantly by rhinoviruses, which are small, non-enveloped RNA viruses. The infection primarily targets the nasal mucosa and nasopharynx, leading to inflammation and increased mucus production. Transmission occurs via respiratory droplets and direct contact with contaminated surfaces. The hallmark clinical features include nasal congestion, rhinorrhea, sneezing, and mild pharyngitis. The disease is significant due to its high prevalence, especially in fall and spring, and its role in precipitating complications such as secondary bacterial sinusitis or exacerbations of asthma and chronic obstructive pulmonary disease. Diagnosis is usually clinical, based on characteristic symptoms and epidemiologic context.

Inciting Event

Inhalation of aerosolized respiratory droplets containing rhinovirus is the primary trigger.
Direct contact with contaminated surfaces followed by hand-to-nose contact initiates infection.
Seasonal outbreaks often follow increased indoor crowding and cooler weather.

Latency Period

Incubation period ranges from 1 to 3 days after exposure to rhinovirus before symptom onset.
Viral replication peaks within 2 to 3 days, correlating with symptom severity.

Diagnostic Delay

Symptoms overlap with other viral respiratory infections, leading to clinical misattribution.
Lack of specific diagnostic tests in routine practice results in empirical diagnosis.
Mild and self-limited nature often causes patients to delay seeking medical evaluation.

Clinical Presentation

Signs & Symptoms

Nasal congestion and clear rhinorrhea are hallmark symptoms.
Sneezing and sore throat commonly occur early in illness.
Cough develops as the illness progresses due to postnasal drip.
Mild fever or low-grade temperature is possible but high fever is uncommon.
Headache and malaise may accompany the viral infection.

History of Present Illness

Initial symptoms include sore throat and nasal congestion followed by rhinorrhea within 24 hours.
Sneezing and cough develop early and persist for 7 to 10 days.
Symptoms peak around day 2 to 3 and gradually resolve without fever or systemic toxicity.
Mild headache and malaise may accompany upper respiratory symptoms.

Past Medical History

History of frequent upper respiratory infections increases likelihood of recurrent colds.
Chronic allergic rhinitis or asthma may exacerbate symptom severity.
Immunodeficiency states predispose to prolonged or complicated infections.

Family History

There are no known hereditary syndromes directly associated with susceptibility to the common cold.
Family members often share environmental exposures that increase transmission risk.

Physical Exam Findings

Nasal mucosa erythema and swelling with clear rhinorrhea are typical findings.
Pharyngeal erythema without exudate is commonly observed.
Mild cervical lymphadenopathy may be present due to immune activation.
Conjunctival injection can occasionally accompany symptoms.
Normal lung auscultation without wheezing or crackles helps exclude lower respiratory infection.

Diagnostic Workup

Diagnostic Criteria

Diagnosis of the common cold is primarily clinical, based on the presence of acute onset of symptoms such as nasal congestion, rhinorrhea, sneezing, and sore throat without fever or with low-grade fever. Laboratory testing is rarely required but can include PCR assays of nasal swabs to detect rhinovirus RNA in atypical or severe cases. The absence of systemic signs like high fever or purulent nasal discharge helps differentiate it from bacterial infections. Imaging and other diagnostic tests are generally not indicated unless complications are suspected.

Pathophysiology

Key Mechanisms

Infection of nasal epithelial cells by rhinovirus initiates the disease process.
Activation of innate immune response leads to release of proinflammatory cytokines causing symptoms.
Increased vascular permeability results in nasal congestion and rhinorrhea.
Mucosal edema and glandular hypersecretion contribute to nasal obstruction and discharge.
Neural reflex stimulation causes sneezing and cough.

Involvement	Details
Organs	Nose is the main organ involved, presenting with congestion, rhinorrhea, and sneezing due to viral infection.
Organs	Pharynx may be involved causing sore throat as part of upper respiratory tract symptoms.
Tissues	Nasal mucosa is the primary tissue affected, where viral replication and inflammation cause symptoms.
Tissues	Respiratory epithelium lining the upper airway is damaged by viral infection leading to impaired mucociliary clearance.
Cells	Epithelial cells of the nasal mucosa serve as the primary site of rhinovirus entry and replication.
	Neutrophils infiltrate the nasal mucosa contributing to inflammation and symptom development.
	Mast cells release histamine and other mediators causing nasal congestion and rhinorrhea.
Chemical Mediators	Histamine released by mast cells causes vasodilation and increased vascular permeability leading to nasal congestion.
	Interleukin-8 (IL-8) attracts neutrophils to the site of infection amplifying inflammation.
	Bradykinin contributes to nasal mucosal swelling and pain sensation during infection.

Treatments

Pharmacological Treatments

Decongestants
- Mechanism:
  - Stimulate alpha-adrenergic receptors causing vasoconstriction and reduced nasal mucosal edema
- Side effects:
  - Nasal irritation
  - Rebound congestion
  - Increased blood pressure
- Clinical role:
  - Supportive
Analgesics and antipyretics (e.g., acetaminophen, ibuprofen)
- Mechanism:
  - Inhibit cyclooxygenase enzymes reducing prostaglandin synthesis to relieve pain and fever
- Side effects:
  - Gastrointestinal upset
  - Liver toxicity (acetaminophen)
  - Renal impairment (NSAIDs)
- Clinical role:
  - Supportive
Antihistamines (first-generation)
- Mechanism:
  - Block H1 histamine receptors to reduce rhinorrhea and sneezing
- Side effects:
  - Sedation
  - Dry mouth
  - Dizziness
- Clinical role:
  - Supportive

Non-pharmacological Treatments

Adequate hydration to maintain mucosal moisture and facilitate mucus clearance.
Rest to support immune function and recovery.
Use of saline nasal sprays or irrigation to relieve nasal congestion and clear secretions.
Humidified air to soothe irritated nasal passages and reduce mucosal dryness.

Prevention

Pharmacological Prevention

No approved antiviral agents effectively prevent rhinovirus infection.
Intranasal interferons have been studied but are not routinely used due to side effects.
Zinc lozenges may reduce duration if started early but are not preventive.
No vaccine is currently available for the common cold caused by rhinovirus.

Non-pharmacological Prevention

Frequent handwashing reduces transmission by removing viral particles.
Avoiding close contact with infected individuals limits exposure to respiratory droplets.
Proper respiratory hygiene such as covering coughs and sneezes decreases spread.
Disinfecting commonly touched surfaces reduces fomite-mediated transmission.
Maintaining good overall health and adequate sleep supports immune defense.

Outcome & Complications

Complications

Secondary bacterial sinusitis can develop from impaired mucociliary clearance.
Acute otitis media is a common complication especially in children.
Exacerbation of asthma or chronic obstructive pulmonary disease may occur.
Lower respiratory tract infections such as bronchitis or pneumonia are rare but possible.

Short-term Sequelae	Long-term Sequelae
Persistent cough lasting up to 3 weeks due to airway inflammation. Postnasal drip causing throat irritation and hoarseness. Transient fatigue and malaise during recovery phase. Temporary anosmia or hyposmia due to nasal mucosal swelling.	No significant long-term sequelae typically result from uncomplicated common cold. Repeated infections may contribute to chronic airway hyperreactivity in susceptible individuals. Rarely, viral infections can trigger chronic sinusitis development.

Differential Diagnoses

Common Cold (Rhinovirus) versus Influenza

Common Cold (Rhinovirus)	Influenza
Gradual onset with mild fever or afebrile and predominantly upper respiratory symptoms lasting 5-10 days	Abrupt onset with high fever, myalgia, and severe malaise lasting 3-7 days
Negative influenza testing; rhinovirus PCR may be positive	Positive rapid influenza antigen or PCR test
Infection caused by rhinovirus	Infection caused by influenza A or B virus

Common Cold (Rhinovirus) versus Allergic Rhinitis

Common Cold (Rhinovirus)	Allergic Rhinitis
Acute onset of nasal congestion, sore throat, and cough often with mild systemic symptoms	Recurrent sneezing, nasal congestion, and clear rhinorrhea triggered by allergens without systemic symptoms
Normal IgE and no eosinophilia	Elevated serum IgE and eosinophilia
Minimal response to antihistamines; supportive care recommended	Improvement with antihistamines and intranasal corticosteroids

Common Cold (Rhinovirus) versus Acute Bacterial Sinusitis

Common Cold (Rhinovirus)	Acute Bacterial Sinusitis
Symptoms peak within 2-3 days and improve within 7-10 days	Symptoms persist >10 days or worsen after initial improvement
Predominantly clear nasal discharge and mild systemic symptoms	Facial pain/pressure, purulent nasal discharge, and fever
Self-limited; antibiotics not routinely indicated	Improvement with antibiotics targeting common sinus pathogens

Common Cold (Rhinovirus) versus COVID-19

Common Cold (Rhinovirus)	COVID-19
No known exposure or low community prevalence	Recent exposure to confirmed COVID-19 case or high community transmission
Negative SARS-CoV-2 testing	Positive SARS-CoV-2 PCR or antigen test
Rare anosmia and primarily upper respiratory symptoms without systemic features	Frequent anosmia, ageusia, and systemic symptoms including fever and fatigue

Common Cold (Rhinovirus) versus Respiratory Syncytial Virus (RSV) Infection

Common Cold (Rhinovirus)	Respiratory Syncytial Virus (RSV) Infection
Common in all ages but primarily mild upper respiratory symptoms in adults	Common in infants and young children causing bronchiolitis
Limited to upper respiratory tract symptoms without wheezing	Progression to lower respiratory tract infection with wheezing and respiratory distress
Negative RSV testing; rhinovirus PCR positive	Positive RSV antigen or PCR test